期刊文献+

芦青颗粒对流感治疗作用的临床分析 被引量:4

Therapeutical Effect of Luqing Particles on Influenza
下载PDF
导出
摘要 目的:观察芦青颗粒对流感的治疗作用。方法:将1360例流感病例随机分成两组,治疗组680例,服用芦青颗粒,对照组680例,服用抗病毒口服液。结果:治疗组治愈率66.76%,总有效率96.47%,与对照组相比较差异有显著性意义。结论:芦青颗粒具有抗病毒、抗菌、解热、消炎等多重功效,对流感有良好的治疗效果。 Objective:To observe the therapeutical effect of Luqing particles on influenza so as to guide the clinical work.Methods:1360 cases with influenza were randomly divided into two groups-the treatment group(n=680) and the control group(n=680).The patients in the treatment group take Luqing particles.Usage:three times everyday,one bag(10 grams)every time,taking orally and seven days as a course.The patients in the control group take anti-virus oral liquid.Usage:three times everyday,10 mL every time,taking orally and seven days as a course.Results:The healing rate in the treatment group is 66.76% and utility rate is 96.47%.It has significant statistic difference compared with that in the control group.Conclusions:Luqing particles have effect on anti-virus,anti-bacterio,remove fever and eliminate inflammation.So it has satisfactory therapeutical effect on influenza.
出处 《辽宁中医杂志》 CAS 北大核心 2005年第7期628-629,共2页 Liaoning Journal of Traditional Chinese Medicine
基金 广东省中医药管理局科研项目(2040065)
关键词 芦青颗粒 流感 中药 临床观察 Luqing particles influenza Chinese herb clinical observation
  • 相关文献

参考文献8

二级参考文献28

  • 1彭怀仁.中医方剂大辞典:8分册10分册[M].北京:人民卫生出版社,1997.103,1011.
  • 2谢鸣.齐剂学[A]..21世纪规划教材[C].北京:人民卫生出版社,2002.53.
  • 3[1]Douglas RGJ. Prophylaxis and treatment of influenza[J]. N EngJ Med, 1990,322:443.
  • 4[2]Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors[J].Lancet, 2000, 355:827.
  • 5[3]Covington E, Mendel DB, Escarpe PA, et al. Phenotypic and genotypic assay of influenza virus neuraminidase indicates a low incidence of viraldrug resistance during treatment with oseltamivir[J]. Ⅱ International Symposium on Influenza and other Respratory Virus,1999,11:10.
  • 6[4]He G, Massarella J, Ward P. Summary of the clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite (Ro 64-0802)[J].Clin Pharmacokinet, 1999,37:471.
  • 7[5]Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of oralneuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial (US oral neuraminidase study group)[J].JAMA, 2000,283:1 016.
  • 8[6]Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomized controlled trial (neuraminidase inhibitor flu treatment investigator group)[J]. Lancet, 2000,355:1845.
  • 9[7]Hayden FG, Atmar RL, Schilling M, et al. Safety and efficacy of a selective oral neuraminidase inhibitor (oseltamivir) to prevent influenza[J].N Engl J Med, 1999,341:1 336.
  • 10[8]Silagy C, Campion K, Keeno O, et al. Randomized trial of efficacy andsafety of inhaled Zanamivir in treatment of influenza A and B virus infection. The MIST(Management of Influenza in the Southern Hemisphere Trialists) Study Group[J].Lancet,1998,352:1 877.

共引文献41

同被引文献59

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部